Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.
Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase. Mutation D409H is the third most frequent in Spanish patients, accounting for 5.7% of all mutated alleles. This allele is associated mainly with the neurological forms of the disease. Recently, homozygosity for the D409H mutation has been associated with a particular phenotype, including specific cardiovascular symptoms. Here we report a second Spanish patient bearing the D409H/D409H genotype with a very early manifestation of the disease. The patient started enzyme replacement therapy at 3 months of age. A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.
Chabás
A
A
Institut de Bioquímica Clínica, Planta Baixa, Barcelona, Spain.
Gort
L
L
Montfort
M
M
Castelló
F
F
Domínguez
M C
MC
Grinberg
D
D
Vilageliu
L
L
D005776:Gaucher Disease / Q000188:drug therapy / Q000235:genetics*; D005819:Genetic Markers; D005962:Glucosylceramidase / Q000235:genetics / Q000627:therapeutic use; D006239:Haplotypes; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D017354:Point Mutation / Q000235:genetics*; D018807:Polymorphism, Single-Stranded Conformational; D013030:Spain
D005819:Genetic Markers; C070292:alglucerase; D005962:Glucosylceramidase